Freedman, A. N., Yu, B., Gail, M. H., Costantino, J. P., Graubard, B. I., Vogel, V. G., . . . McCaskill-Stevens, W. (2011). Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older. American Society of Clinical Oncology.

Freedman, Andrew N., Binbing Yu, Mitchell H. Gail, Joseph P. Costantino, Barry I. Graubard, Victor G. Vogel, Garnet L. Anderson, and Worta McCaskill-Stevens. Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older. American Society of Clinical Oncology, 2011.

Freedman, Andrew N., et al. Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older. American Society of Clinical Oncology, 2011.